These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8970997)

  • 41. Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants.
    Fujita M; Sakurai A; Doi N; Miyaura M; Yoshida A; Sakai K; Adachi A
    Microbes Infect; 2001 Nov; 3(13):1093-9. PubMed ID: 11709289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.
    Stopak K; de Noronha C; Yonemoto W; Greene WC
    Mol Cell; 2003 Sep; 12(3):591-601. PubMed ID: 14527406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1.
    Sova P; Volsky DJ
    J Virol; 1993 Oct; 67(10):6322-6. PubMed ID: 8371360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
    Aiken C; Trono D
    J Virol; 1995 Aug; 69(8):5048-56. PubMed ID: 7541845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The middle to 3' end of the HIV-1 vif gene sequence is important for vif biological activity and could be used for antisense oligonucleotide targets.
    Barnor JS; Miyano-Kurosaki N; Takaku H; Yamaguchi K; Sakamoto A; Ishikawa K; Yamamoto N; Osei-Kwasi M; Ofori-Adjei D
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1745-61. PubMed ID: 16438045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subtle mutations in the cysteine region of HIV-1 Vif drastically alter the viral replication phenotype.
    Fujita M; Sakurai A; Yoshida A; Matsumoto S; Miyaura M; Adachi A
    Microbes Infect; 2002 May; 4(6):621-4. PubMed ID: 12048031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The innate antiretroviral defense of human cells, based on the DNA editing].
    Pupecka M; Pacak A
    Postepy Biochem; 2006; 52(3):247-52. PubMed ID: 17201059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human immunodeficiency virus 1 (HIV-1) virion infectivity factor (Vif) is part of reverse transcription complexes and acts as an accessory factor for reverse transcription.
    Carr JM; Coolen C; Davis AJ; Burrell CJ; Li P
    Virology; 2008 Mar; 372(1):147-56. PubMed ID: 18037155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complementation of human immunodeficiency virus type 1 vif mutants in some CD4+ T-cell lines.
    Hevey M; Donehower LA
    Virus Res; 1994 Sep; 33(3):269-80. PubMed ID: 7527173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity.
    Ma XY; Sova P; Chao W; Volsky DJ
    J Virol; 1994 Mar; 68(3):1714-20. PubMed ID: 8107232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversal of HIV drug resistance and novel strategies to curb HIV infection: the viral infectivity factor Vif as a target and tool of therapy.
    Mezei M; Minarovits J
    Curr Drug Targets; 2006 Jul; 7(7):881-5. PubMed ID: 16842218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
    Sheehy AM; Gaddis NC; Choi JD; Malim MH
    Nature; 2002 Aug; 418(6898):646-50. PubMed ID: 12167863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps.
    Courcoul M; Patience C; Rey F; Blanc D; Harmache A; Sire J; Vigne R; Spire B
    J Virol; 1995 Apr; 69(4):2068-74. PubMed ID: 7884852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core.
    Zhang H; Dornadula G; Orenstein J; Pomerantz RJ
    J Hum Virol; 2000; 3(3):165-72. PubMed ID: 10881997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA.
    Guo J; Henderson LE; Bess J; Kane B; Levin JG
    J Virol; 1997 Jul; 71(7):5178-88. PubMed ID: 9188585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant.
    Opi S; Kao S; Goila-Gaur R; Khan MA; Miyagi E; Takeuchi H; Strebel K
    J Virol; 2007 Aug; 81(15):8236-46. PubMed ID: 17522211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A dual role of the putative RNA dimerization initiation site of human immunodeficiency virus type 1 in genomic RNA packaging and proviral DNA synthesis.
    Paillart JC; Berthoux L; Ottmann M; Darlix JL; Marquet R; Ehresmann B; Ehresmann C
    J Virol; 1996 Dec; 70(12):8348-54. PubMed ID: 8970954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Good to CU.
    Gu Y; Sundquist WI
    Nature; 2003 Jul; 424(6944):21-2. PubMed ID: 12840737
    [No Abstract]   [Full Text] [Related]  

  • 60. Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass.
    Cancio R; Spadari S; Maga G
    Biochem J; 2004 Nov; 383(Pt. 3):475-82. PubMed ID: 15315477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.